Market Highlights: Avidity Biosciences Inc (RNA) Ends on a High Note at 33.62

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

The price of Avidity Biosciences Inc (NASDAQ: RNA) closed at $33.62 in the last session, up 2.94% from day before closing price of $32.66. In other words, the price has increased by $2.94 from its previous closing price. On the day, 1.97 million shares were traded.

Ratios:

We take a closer look at RNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.91 and its Current Ratio is at 16.91. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $70.

On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $70.Scotiabank initiated its Sector Outperform rating on March 07, 2025, with a $70 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when Gallagher Kathleen P. sold 5,875 shares for $32.48 per share. The transaction valued at 190,833 led to the insider holds 50,554 shares of the business.

KATHLEEN GALLAGHER bought 5,875 shares of RNA for $182,008 on Jun 02 ’25. On May 01 ’25, another insider, Gallagher Kathleen P., who serves as the Chief Program Officer of the company, sold 5,875 shares for $32.40 each. As a result, the insider received 190,324 and left with 50,554 shares of the company.

Stock Price History:

Over the past 52 weeks, RNA has reached a high of $56.00, while it has fallen to a 52-week low of $21.51. The 50-Day Moving Average of the stock is 12.97%, while the 200-Day Moving Average is calculated to be -6.06%.

Shares Statistics:

A total of 120.51M shares are outstanding, with a floating share count of 109.84M. Insiders hold about 8.88% of the company’s shares, while institutions hold 107.71% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.